retatrutide facts RETATRUTIDE: A Medication for Diabetes and Weight Loss how do you know if

If retatrutide is approved in the future, that conversation can be had at the point of approval, when the safety profile and access pathway are clearer

Research in people with Type 2 diabetes has shown that GLP-1 receptor agonists may lower the chances of having a heart attack, stroke, or dying from cardiovascular (heart and blood vessel) problems

Lilly announces positive Phase 3 results for retatrutide in adults with obesity

Retatrutide targets GLP-1 and GIP hormones too, but it also mimics the glucagon hormone

Liraglutide-loaded poly (lactic-co-glycolic acid) microspheres: preparation and in vivo evaluation

To answer these questions, lets explore the science, benefits, and potential concerns around this practice